Predictive Value of K i -67 Index in Evaluating Sporadic Vestibular Schwannoma Recurrence: Systematic Review and Meta-analysis.
Kunal VakhariaHirotaka HasegawaChristopher GraffeoMohammad H A NoureldineSalomon Cohen CohenAvital PerryMatthew L CarlsonColin L W DriscollMaria Peris-CeldaJamie J Van GompelMichael J LinkPublished in: Journal of neurological surgery. Part B, Skull base (2022)
Introduction K i -67 is often used as a proliferation index to evaluate how aggressive a tumor is and its likelihood of recurrence. Vestibular schwannomas (VS) are a unique benign pathology that lends itself well to evaluation with K i -67 as a potential marker for disease recurrence or progression following surgical resection. Methods All English language studies of VSs and K i -67 indices were screened. Studies were considered eligible for inclusion if they reported series of VSs undergoing primary resection without prior irradiation, with outcomes including both recurrence/progression and K i -67 for individual patients. For published studies reporting pooled K i -67 index data without detailed by-patient values, we contacted the authors to request data sharing for the current meta-analysis. Studies reporting a relationship between K i -67 index and clinical outcomes in VS for which detailed patients' outcomes or K i -67 indices could not be obtained were incorporated into the descriptive analysis, but excluded from the formal (i.e., quantitative) meta-analysis. Results A systematic review identified 104 candidate citations of which 12 met inclusion criteria. Six of these studies had accessible patient-specific data. Individual patient data were collected from these studies for calculation of discrete study effect sizes, pooling via random-effects modeling with restricted maximum likelihood, and meta-analysis. The standardized mean difference in K i -67 indices between those with and without recurrence was calculated as 0.79% (95% confidence interval [CI]: 0.28-1.30; p = 0.0026). Conclusion K i -67 index may be higher in VSs that demonstrate recurrence/progression following surgical resection. This may represent a promising means of evaluating tumor recurrence and potential need for early adjuvant therapy for VSs.
Keyphrases
- case control
- free survival
- systematic review
- end stage renal disease
- electronic health record
- chronic kidney disease
- ejection fraction
- newly diagnosed
- big data
- peritoneal dialysis
- healthcare
- meta analyses
- high resolution
- type diabetes
- metabolic syndrome
- emergency department
- adverse drug
- patient reported outcomes
- social media
- cross sectional
- clinical trial
- randomized controlled trial
- machine learning
- adipose tissue
- weight loss
- radiation therapy
- radiation induced
- insulin resistance
- hearing loss
- climate change
- neural network